Logo

American Heart Association

  18
  0


Final ID:

Preclinical development of gene-specific therapeutic strategies for cardiomyopathies

  • Parikh, Victoria  ( Stanford University , San Francisco , California , United States )
  • Knollmann, Bjorn  ( VANDERBILT UNIVERSITY , Nashville , Tennessee , United States )
  • Malik, Fady  ( CYTOKINETICS INC. , S San Fran , California , United States )
  • Author Disclosures:
    Victoria Parikh: DO have relevant financial relationships ; Consultant:Lexeo Therapeutics:Active (exists now) ; Consultant:Borealis:Active (exists now) ; Consultant:Nuevocor:Active (exists now) ; Advisor:Constantiam Biosciences:Active (exists now) ; Consultant:BioMarin:Active (exists now) | Bjorn Knollmann: DO have relevant financial relationships ; Advisor:Solid Biosciences:Active (exists now) ; Royalties/Patent Beneficiary:McGrawHill:Active (exists now) | Fady Malik: DO have relevant financial relationships ; Executive Role:Cytokinetics, Inc.:Active (exists now) ; Individual Stocks/Stock Options:Cytokinetics, Inc:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

More abstracts on this topic:
More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available